TY - JOUR
T1 - Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis
AU - Salem, Riad
AU - Vouche, Michael
AU - Baker, Talia
AU - Herrero, Jose Ignacio
AU - Caicedo, Juan Carlos
AU - Fryer, Jonathan
AU - Hickey, Ryan
AU - Habib, Ali
AU - Abecassis, Michael
AU - Koller, Felicitas
AU - Vogelzang, Robert
AU - Desai, Kush
AU - Thornburg, Bartley
AU - Hohlastos, Elias
AU - Resnick, Scott
AU - Lewandowski, Robert J.
AU - Sato, Kent
AU - Ryu, Robert K.
AU - Ganger, Daniel
AU - Kulik, Laura
N1 - Publisher Copyright:
© 2015 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2015/10/23
Y1 - 2015/10/23
N2 - Background.Chronic, obliterative portal vein (PV) thrombosis (PVT) represents a relative contraindication to liver transplantation (LT) in some centers. When PV thromboembolectomy is not feasible, alternative techniques (portacaval hemitransposition, portal arterialization, multivisceral transplantation) are associated with suboptimal outcomes. In cases where a chronically thrombosed PV has become obliterated, we developed PV recanalization (PVR)-transjugular intrahepatic portosystemic shunt (TIPS) to potentiate LT.We evaluated the impact of PVR-TIPS on liver function, transplant eligibility, and long-termoutcomes after LT. Methods. Forty-four patients with chronic obliterative main PVTwere identified during our institutional LTselection committee. After joint imaging review by transplant surgery/radiology, these patients underwent PVR-TIPS to potentiate transplant eligibility. Patients were followed by hepatology/transplant until LT, and ultimately in posttransplant clinic. The TIPS venography and serial ultrasound/MRI were used subsequently to document PV patency. Results. The main PV (MPV) was completely thrombosed in 17 of 44 (39%) patients; near complete (>95%) occlusion was noted in 27 of 44 (61%) patients. Direct transhepatic and transsplenic punctures were required in 11 of 43 (26%) and 3 of 43 (7%) cases, respectively. Technical success was 43 of 44 (98%) cases. At PVRTIPS completion, persistence of MPV thrombus was noted in 33 of 43 (77%) cases. One-month TIPS venography demonstrated complete resolution of MPVthrombosis in 22 of 29 (76%)without anticoagulation. Thirty-six patients were listed for transplantation; 18 (50%) have been transplanted. Eighty-nine percentMPVpatency rate and82%survival were achievedat 5 years. Conclusions.The PVR-TIPS may be considered for patients with obliterative PVTwho are otherwise appropriate candidates for LT. The high rate ofMPV patency post-TIPS placement suggests flow reestablishment as the dominantmechanism of thrombus resolution.
AB - Background.Chronic, obliterative portal vein (PV) thrombosis (PVT) represents a relative contraindication to liver transplantation (LT) in some centers. When PV thromboembolectomy is not feasible, alternative techniques (portacaval hemitransposition, portal arterialization, multivisceral transplantation) are associated with suboptimal outcomes. In cases where a chronically thrombosed PV has become obliterated, we developed PV recanalization (PVR)-transjugular intrahepatic portosystemic shunt (TIPS) to potentiate LT.We evaluated the impact of PVR-TIPS on liver function, transplant eligibility, and long-termoutcomes after LT. Methods. Forty-four patients with chronic obliterative main PVTwere identified during our institutional LTselection committee. After joint imaging review by transplant surgery/radiology, these patients underwent PVR-TIPS to potentiate transplant eligibility. Patients were followed by hepatology/transplant until LT, and ultimately in posttransplant clinic. The TIPS venography and serial ultrasound/MRI were used subsequently to document PV patency. Results. The main PV (MPV) was completely thrombosed in 17 of 44 (39%) patients; near complete (>95%) occlusion was noted in 27 of 44 (61%) patients. Direct transhepatic and transsplenic punctures were required in 11 of 43 (26%) and 3 of 43 (7%) cases, respectively. Technical success was 43 of 44 (98%) cases. At PVRTIPS completion, persistence of MPV thrombus was noted in 33 of 43 (77%) cases. One-month TIPS venography demonstrated complete resolution of MPVthrombosis in 22 of 29 (76%)without anticoagulation. Thirty-six patients were listed for transplantation; 18 (50%) have been transplanted. Eighty-nine percentMPVpatency rate and82%survival were achievedat 5 years. Conclusions.The PVR-TIPS may be considered for patients with obliterative PVTwho are otherwise appropriate candidates for LT. The high rate ofMPV patency post-TIPS placement suggests flow reestablishment as the dominantmechanism of thrombus resolution.
UR - http://www.scopus.com/inward/record.url?scp=84945980532&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84945980532&partnerID=8YFLogxK
U2 - 10.1097/TP.0000000000000729
DO - 10.1097/TP.0000000000000729
M3 - Article
C2 - 25905983
AN - SCOPUS:84945980532
SN - 0041-1337
VL - 99
SP - 2347
EP - 2355
JO - Transplantation
JF - Transplantation
IS - 11
ER -